Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells
- 5 December 2001
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 434 (3) , 109-116
- https://doi.org/10.1016/s0014-2999(01)01548-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Rasagiline, a novel monoamine oxidase-B inhibitor with neuroprotective effects under ischemic conditions in PC12 cellsDrug Development Research, 2000
- Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivationJournal of Neuroscience Research, 1999
- Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitorNeuroReport, 1998
- Involvement of Sphingosine 1-Phosphate in Nerve Growth Factor-Mediated Neuronal Survival and DifferentiationJournal of Neuroscience, 1997
- Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanismJournal of Neuroscience, 1996
- A tissue culture ischemic device to study eicosanoid release by pheochromocytoma PC12 culturesJournal of Neuroscience Methods, 1993
- Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesisJournal of Neuroscience, 1993
- Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibitionJournal of Neuroscience, 1993
- Gangliosides rescue neuronal cells from death after trophic factor deprivationJournal of Neuroscience, 1993
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975